Turning empathy into engagement for The WONDER Foundation

td {padding: 10px;}The latest round of IRA price negotiations has revealed which pharma manufacturers were able to best defend their pricing despite having no walk-away power and limited leverage. By comparing predicted ceiling prices with the final negotiated outcomes, clear patterns begin to emerge. Our experts’ analysis highlights which companies came closest to the best-case scenario and what